Eikon Therapeutics, Inc. Common Stock (EIKN) Earnings Analysis
Eikon Therapeutics, Inc. Common Stock (EIKN) next reports earnings on 2026-08-10, consensus EPS -1.61 USD. Last quarter (2026-05-11) it missed with EPS -2.4616 USD vs -1.978 USD est (-24.4%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -3.20.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EIKN next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -1.61 USD |
| Revenue estimate | n/a |
EIKN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -2.4616 USD | -1.978 USD | -24.4% | Miss |
| 2026-03-30 | -27 USD | -3.56 USD | -658.4% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
EIKN valuation and analyst view
| Trailing P/E | -3.20 |
|---|---|
| Trailing EPS | -3.00364 USD |
| Price / book | 0.94 |
| Dividend yield | 0.00% |
| Market cap | 0.03B |
| Analyst consensus | Sell (0 buy / 0 hold / 1 sell) |
| Avg price target | 5 USD |
Related research pages
Frequently asked questions
When is Eikon Therapeutics, Inc. Common Stock (EIKN)'s next earnings date?
Eikon Therapeutics, Inc. Common Stock is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -1.61 USD.
Did EIKN beat earnings last quarter?
In its 2026-05-11 report, EIKN posted EPS of -2.4616 USD versus a -1.978 USD estimate — a miss of 24.4%.
What is EIKN's earnings track record?
Over the last 2 reported quarters with consensus data, EIKN beat estimates 0 times (0%).
What is EIKN's current P/E ratio and EPS?
EIKN trades at a trailing P/E of -3.20 on trailing EPS of -3.0036449993909144 USD.
What do analysts rate EIKN?
Analyst consensus is "Sell" across 1 ratings (0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell). Average 12-month price target: 5 USD.